Abrdn Life Sciences Investors (HQL)
| Market Value | 637.96M |
| Revenue (ttm) | 1.11M -66.1% |
| Net Income | 198.17M |
| EPS | 6.52 |
| Shares Out | 30.41M |
| PE Ratio | 3.20 |
| Forward PE | n/a |
| Dividend | $2.24 (10.68%) |
| Ex-Dividend Date | Aug 24, 2026 |
| Volume | 141,130 |
| Open | 20.96 |
| Previous Close | 20.87 |
| Day's Range | 20.72 - 21.43 |
| 52-Week Range | 13.88 - 22.67 |
| Beta | 0.71 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About HQL
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap c... [Read more]
Financial Performance
In fiscal year 2025, HQL's revenue was $1.94 million, a decrease of -51.30% compared to the previous year's $3.98 million. Earnings were $85.59 million, an increase of 0.35%.
Financial StatementsNews
How We're Playing ‘AI 2.0' For Big Dividend Payouts
If you're wondering whether the rally in tech stocks is fading, well, it is.
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update
PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Health...
abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in Distribution Rate
PHILADELPHIA, PA / ACCESSWIRE / February 9, 2024 / abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) (collectively, the "Funds") each...
abrdn Announces Its Appointment to Four U.S. Specialist Healthcare Closed-End Funds, New Board of Trustees to the Funds and Fund Name Changes
PHILADELPHIA, PA / ACCESSWIRE / October 27, 2023 / Effective close of business today, October 27, 2023, abrdn Inc. ("abrdn") assumed responsibility for the management of the four (4) former Tekla Capi...
Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.
BOSTON--(BUSINESS WIRE)--Tekla Capital Management LLC (Tekla) announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its...
Tekla Capital Management LLC Announces Closing of Transaction With abrdn
Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manag...
Tekla Life Sciences Investors Paid Distribution
BOSTON--(BUSINESS WIRE)--On September 29, 2023, Tekla Life Sciences Investors paid a distribution of $0.32 per share. It is currently estimated that this distribution is derived from net realized long...
Tekla Funds Announce Second Adjournment of Special Meetings and Urge Shareholder Participation to Limit the Need for Further Solicitation Efforts
BOSTON--(BUSINESS WIRE)--Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today ann...
Tekla Life Sciences Investors Declares Distribution
BOSTON--(BUSINESS WIRE)--On August 15, 2023, Tekla Life Sciences Investors declared a distribution of $0.32 per share. The record date for the distribution is August 25, 2023 and the payable date is S...
Tekla Funds Announce Adjournment of Special Meetings
BOSTON--(BUSINESS WIRE)--Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today ann...
Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program
BOSTON--(BUSINESS WIRE)--Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase progra...
How To Protect Your Wealth, Grab 7%+ Dividends, In This Pullback
You can be forgiven if your stomach tightens just a bit when you go to check your retirement account.
5 Dividend Funds Yielding Up To 27.2%
Double-digit dividends are rare. A sky-high yield of 27.2% is an outright income unicorn.
Tekla Life Sciences Investors Declares Stock Distribution
BOSTON--(BUSINESS WIRE)--On May 18, 2021, Tekla Life Sciences Investors declared a stock distribution of $0.41 per share. The record date for the stock distribution is May 28, 2021 and the payable dat...
Tekla Life Sciences Investors Declares Cash Distribution
BOSTON--(BUSINESS WIRE)--On December 21, 2020, Tekla Life Sciences Investors declared a special cash distribution of $0.02 per share in order to satisfy annual tax distribution requirements. The recor...
Top 6 Mutual Funds And ETFs To Buy For 2020
Each year, MoneyShow asks the nation’s leading financial newsletter advisors for their top recommendations for the coming year. In our Top Picks 2020 Report, several experts chose mutual funds and ETF...